Geode Capital Management
TECX

Geode Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Geode Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3M Buy
270,461
+2,188
+0.8% +$64.3K ﹤0.01% 2588
2026
Q1 		$8.29M Buy
268,273
+4,713
+2% +$116K ﹤0.01% 2479
2025
Q4 		$5.5M Sell
263,560
-5,793
-2% -$108K ﹤0.01% 2714
2025
Q3 		$4.23M Sell
269,353
-2,904
-1% -$59.9K ﹤0.01% 2869
2025
Q2 		$5.41M Buy
272,257
+192,770
+243% +$3.91M ﹤0.01% 2687
2025
Q1 		$1.41M Buy
79,487
+1,903
+2% +$62K ﹤0.01% 3179
2024
Q4 		$3.58M Buy
77,584
+705
+0.9% +$29.8K ﹤0.01% 2906
2024
Q3 		$2.33M Buy
76,879
+45,846
+148% +$838K ﹤0.01% 3076
2024
Q2 		$511K Sell
31,033
-4
-0% -$64 ﹤0.01% 3559
2024
Q1 		$477K Buy
31,037
+494
+2% +$7.82K ﹤0.01% 3636
2023
Q4 		$499K Buy
30,543
+1,117
+4% +$19.2K ﹤0.01% 3612
2023
Q3 		$544K Buy
29,426
+781
+3% +$13.8K ﹤0.01% 3570
2023
Q2 		$327K Buy
28,645
+1,102
+4% +$12.5K ﹤0.01% 3818
2023
Q1 		$331K Sell
27,543
-4,617
-14% -$64.3K ﹤0.01% 3812
2022
Q4 		$275K Sell
32,160
-78
-0.2% -$686 ﹤0.01% 3931
2022
Q3 		$248K Hold
32,238
– – ﹤0.01% 4080
2022
Q2 		$355K Sell
32,238
-29,902
-48% -$352K ﹤0.01% 3946
2022
Q1 		$984K Buy
62,140
+7,956
+15% +$164K ﹤0.01% 3626
2021
Q4 		$2.5M Buy
54,184
+6,110
+13% +$351K ﹤0.01% 3269
2021
Q3 		$3.22M Sell
48,074
-3,748
-7% -$308K ﹤0.01% 3154
2021
Q2 		$5.53M Buy
51,822
+2,179
+4% +$258K ﹤0.01% 2827
2021
Q1 		$7.56M Buy
49,643
+7,401
+18% +$1.2M ﹤0.01% 2550
2020
Q4 		$7.07M Buy
42,242
+6,686
+19% +$1.19M ﹤0.01% 2399
2020
Q3 		$5.55M Buy
35,556
+871
+3% +$175K ﹤0.01% 2328
2020
Q2 		$7.26M Buy
34,685
+4,922
+17% +$1.01M ﹤0.01% 2116
2020
Q1 		$5.56M Buy
29,763
+5,097
+21% +$1.2M ﹤0.01% 2084
2019
Q4 		$5.96M Buy
24,666
+1,455
+6% +$281K ﹤0.01% 2345
2019
Q3 		$3.93M Buy
23,211
+10,946
+89% +$2.48M ﹤0.01% 2526
2019
Q2 		$2.39M Buy
12,265
+1,911
+18% +$412K ﹤0.01% 2833
2019
Q1 		$2.74M Buy
10,354
+3,169
+44% +$579K ﹤0.01% 2666
2018
Q4 		$1.44M Buy
7,185
+1,729
+32% +$527K ﹤0.01% 2944
2018
Q3 		$3.4M Buy
+5,456
New +$2.42M ﹤0.01% 2604

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Geode Capital Management's TECX Position: Q2 2026 in Review

Geode Capital Management increased its Tectonic Therapeutic (TECX) stake by 0.82% in Q2 2026, buying an estimated $64.3K and bringing the position to 270,461 shares worth $9.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

Geode Capital Management first reported a position in TECX in Q3 2018 and has held it in 32 quarters since. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Geode Capital Management held 270,461 shares of Tectonic Therapeutic worth $9.3M as of Q2 2026.
  • Geode Capital Management bought 2,188 Tectonic Therapeutic shares in Q2 2026, an estimated $64.3K.
  • Tectonic Therapeutic made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2588 holding.
  • Geode Capital Management first reported a position in Tectonic Therapeutic in Q3 2018 and has held it in 32 quarters since.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.